Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Q4 Results and Discussion
View:
Post by Quentin30 on Mar 04, 2024 2:40pm

Q4 Results and Discussion

Well, this is probably one of the most hotly awaited opportunities for ONCY management to add some meat to the bone of their 'aspirations'.

Yes, Matt, we know you are in discussions with potential partners... you have been in perpetual discussions for over 10 years...

1) What additional data do you need (does the FDA want to see) to start Phase III ?
2) When will you submit the trial protocol - or have you already done so?
3) Who will pay for either of the two phase III's?

IF, Matt indicates that they will go it alone, I would consider this a massive red flag... it means that ALL potential partners have sifted through and spat out their clinical data, and come to the conclusion that ONCY is uninvestable...

If that were to happen, I think it's pretty much game over...  but IF they are in final discussions with a partner... then it's game on...
Comment by 13X2413 on Mar 04, 2024 2:43pm
I'm guessing that we're in for a kick in the b**ls on Thursday. This strangely timed conference call coupled with today's sell off is deeply concerning. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities